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Background: Carbon nanodots (CD), a new class of carbon nanomaterials with sizes below 10 nm, have recently
attracted wide attention due to their superiority in water solubility, chemical inertness, and resistance to
photobleaching. As a result, CD has found important and wide applications in energy, catalysis, biological labeling,
bioimaging and drug delivery. On the other hand, due to the lack of available toxicity data, there is a growing
concern regarding the potential risks of CD. Hence, accurate assessment of the cytotoxicity of CD has become
more important than ever before. The lactate dehydrogenase (LDH) assay is widely used to detect cytotoxicity of
various nanoparticles including CD. Many recent studies used LDH assay to study the CD toxicity in various cells.
However, these studies failed to further examine whether the CD were interfering with the LDH assay which would
alter their findings.
Findings: This study investigated the possible interference of carbon nanodots on the LDH assay in human
monocyte THP-1 cells. Monocytes are known to be involved in inflammable vascular diseases, and have been
suggested to be the targets for CD exposure. In this study, the cytotoxicity of CD in concentrations ranging from
0.075 to 0.60 mg/mL, was determined by using the LDH assay. To validate the results of LDH assay, the cell
counting method with trypan blue staining was used. With 24 hours incubation time, the cell viability of THP-1 was
significantly decreased according to the trypan blue staining method. Whereas, in the LDH assay, the CD was found
to interfere in a dose-dependent manner with the NADH absorbance measurements at 340 nm.
Conclusions: This study represents the first report on the negative interference of CD on LDH assay, and caution
should be observed when evaluating the cytotoxicity of CD.
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Carbon nanomaterial production has increased globally in
the past few years and risk assessment for carbon nano-
materials is not completely established (Tsuji et al. 2006).
Their physical and chemical properties allow them to be
great candidates for imaging, photocatalysis, cancer cell
inhibition, and disease diagnosis (Hsu et al. 2013; Juzenas
et al. 2013; Tang et al. 2013; Zhang et al. 2013). Carbon* Correspondence: prof.chiu@gmail.com; z_jia@uncg.edu
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in any medium, provided the original work is pnanodots (CD), a new class of carbon nanomaterials
with sizes below 10 nm, have recently attracted wide
attention due to their superiority in water solubility,
chemical inertness, and resistance to photobleaching
(Baker and Baker 2010; Hsu and Chang 2012; Shi et al.
2011; Zhou et al. 2012). As a result, CD has found import-
ant and wide applications in energy, catalysis, biological la-
beling, bioimaging and drug delivery (Baker and Baker 2010;
Hsu and Chang 2012; Shi et al. 2011; Zhou et al. 2012). Al-
though CD are considered to be biocompatible, there have
been cases where CD is identified as toxic agent for various
biological tissues (Hsu et al. 2013; Zhang et al. 2013). There-
fore, it is important that the risk assessment is thoroughly
examined before administering them for medical use. The
correlation between exposure to nanoparticles and vascularn Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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Beck and Offenbacher 2001). Monocytes are known to
play crucial role in the development of inflammable vas-
cular diseases and have been suggested to be significant
targets for nanoparticle exposure (Prach et al. 2013).
Although there are different types of assays that can be
applied to evaluate the cytotoxicity of nanomaterials, lactate
dehydrogenase (LDH) assay has been considered to be the
gold standard for measuring cytotoxicity (Kroll et al. 2012).
The LDH enzyme is shared amongst all cell types and is
released upon damage to the cell membrane. The LDH
assay has been used to access the properties of CD, as a
way to support CD induces apoptosis instead of necrosis
(Hsu et al. 2013). Hsu et al., measured the integrity of the
cell membranes of three different cancer cell lines MCF-7,
MDA-MB-231, and HeLa by using the LDH assay. They
found that after 24 h incubation with CD there wasn’t any
increase in the release of LDH in any of the selected cell
lines (Hsu et al. 2013). However, they did not further exam-
ine whether the CD were interfering with the LDH assay
which would alter their findings. This study focuses on the
investigation of possible interference of carbon nanodots
on the LDH assay in human monocyte THP-1 cells.
Methods
Synthesis and characterization of carbon nanodots
Carbon nanodots were synthesized as reported recently by
us (Hu et al. 2013). Briefly, 0.50 g citric acid (CA) was dis-
solved in 5.0 mL distilled deionized (DDI) water followed
by mixing with various amounts of 1,2-ethylenediamine
(EDA, 0.00–0.47 g) under vigorous stirring in glass vials.
The solution was then heated in a domestic microwave
oven (800 W) for 4.0 min and the glass vial was cooled
down to room temperature. The reddish brown and
foamy solid was then dissolved in DDI water and dialyzed
through a dialysis membrane with MWCO of 500–1000 Da
(Spectrum Laboratories, Rancho Dominguez, CA, USA) and
a clear and reddish brown aqueous solution was lyophilized
to obtain ca. 0.050 g dry C-dots product. Various optical
determinations including UV–vis absorption, photolumines-
cence spectroscopy, IR spectroscopy and mass spectrum
were employed to characterize the as-synthesized C-dots as
described by us recently (Hu et al. 2013).
Cell culture and treatment
The human monocyte THP-1 cells (ATCC, Manassas, VA)
were maintained in RPMI-1640 medium supplemented
with fetal bovine serum (10%), penicillin-streptomycin
(1%) antibiotic in 5% CO2 at 37°C. All these chemicals and
media were purchased from Sigma-Aldrich (St Louis, MO).
Prior to confluence, the cells were collected and centrifuged
for 10 min, 4°C, 1000 g. The supernatant was decanted
and the cell pellet was re-suspended in Dulbecco’s
Modified Eagle’s medium (DMEM) The cells were thenseeded in a 24-well plate at a density of 4.0 × 105 cells
per mL. CD (0.60 mg) were mixed with DMEM (1 mL),
an aliquot (400 uL) of this mixture was added to each
well, and was incubated for 24 h.
LDH assay
The cytotoxic effects of CD were first measured by
quantitating the release of lactate dehydrogenase (LDH)
from the THP-1 cells. Following incubation, an aliquot
(200 uL per well) of treated cells were centrifuged for
5 min, 4°C, 13,000 × g. The untreated cells (200 uL per
well) were sonicated then centrifuged. The supernatants
were collected for LDH measurements. Reagents for
LDH assay were 60 uL per well of 0.8 mg/mL pyruvate,
60 uL per well of 3 mg/mL NADH. A total assay volume
of 600 uL was made up with 1X phosphate buffered saline
(PBS, pH 7.4). NADH was added last, and the cuvette was
immediately placed in the spectrophotometer. In the spec-
trophotometer, the oxidation of NADH was monitored at
340 nm for over 5 min.
Trypan blue viability assay
The cell number and cell viability were determined by
using the cell counting method. Cells (100 uL per well)
were mixed with trypan blue dye (100 uL) and 20 uL of
this cell-dye mixture was loaded onto a hemacytometer.
Each mixture was counted four times by using all four
grids on the hemacytometer. When digital EVOS micro-
scope was used, an aliquot of 10 uL of the cell-dye mixture
was added on a microscope slide.
Measurement of CD absorbance with a
spectrophotometer
The CD (0.15 mg) was dissolved in deionized water
(0.25 mL) for absorbance measurements. Serial dilutions
were performed for concentrations of 0.45, 0.30, 0.15,
0.075 mg/mL. Each CD dilution (10 uL) was added to
the LDH reagents (60 uL NADH, 60 uL pyruvate, and
490 uL 1X PBS), and absorbance was read at 340 nm.
Statistical analyses
Data were analyzed with one-way ANOVA and are
expressed as mean ± SEM based on quadruple and
triplicate observations, respectively. After ANOVA,
statistical significance between the treatment and control
groups was determined by Student t-test and defined
at p < 0.05 level.
Results and discussion
Recent studies have demonstrated that exposure to
nanoparticles could elevate the risk of vascular diseases.
Monocytes are known to be involved in inflammable vas-
cular diseases, and have been suggested to be the targets
for nanoparticle exposure. In this study, the cytotoxicity of
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Figure 1 Results of LDH assays of THP-1 cells with or without CD. Cells were treated without or with 0.15 mg/mL and 0.30 mg/mL CD for
24 h. Blank contained PBS buffer only. Supernatant from treated cells (TC) was measured by mixing 5 or 10 uL of supernatant with 595 or 590 uL
of LDH reagents, respectively. Positive control (PC) consisted of lysate from control cells in the absence of CD.
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ging from 0.075 to 0.60 mg/mL, was determined by using
the LDH assay. Figure 1 displays the LDH absorbance in
the presence and absence of CD. There was a pronounced
effect of LDH release in the cell lysate (Figure 1, positive
control) indicating LDH was utilizing NADH in its con-
version to pyruvate. The decrease in NADH absorbance
over time confirmed that the reagents and instrument
were operating properly. However, after 24 h incubation
with 0.15 mg/mL and 0.30 mg/mL of CD, the CD did not
cause any increase in the release of LDH from the THP-1
cells (Figure 1).
To validate the results of LDH assay, the cell counting
method with trypan blue staining was used (Figure 2).Cell Viability byTr
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Figure 2 Cell viability of THP-1 cells determined by cell counting with
of viable cells was normalized to the negative control, which was calculate
number of living cells in negative control) with 100%. Data are expressed aIncubation of cells with various concentrations of CD
for 24 hours caused a significant decrease in cell viability
measured by trypan blue staining (Figure 2). The cell
morphology changes by CD were further examined
with a digital microscope (Figure 3). In comparison to
the control, the cells treated with CD display signifi-
cant changes in cell morphology including a loss of
uniformity and detritus surrounding the cell clusters as
indicated by the arrows in Figure 3. The inconsistency
results between Figure 1 (LDH assay) and Figures 2
and 3 (trypan blue staining and digital microscope) by
CD treatments lead us to suspect CD could interfere
with the NADH absorbance measurements in the LDH
assay (Figure 1).ypan Blue  
*  
0.30 mg/mL CD 
Trypan blue staining method with or without CD. The percentage
d by multiplying the ratio of (number of living cells in treated sample:
s mean ± SEM from four experiments. *, p < 0.05 vs. control.
Figure 3 Morphology change of THP-1 cells in absence and presence of CD. There are distinct changes between the negative control and
the treated cells. The arrows show that the cells have significant changes in cell morphology.
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confirm its interference with the LDH assay (Figure 4).
The absorbance of CD in the absence of THP-1 cells
was measured in concentrations ranging from 0.075 to
0.60 mg/mL. The absorbance of CD at 340 nm increased
as the concentrations increased (R2 = 0.9883, Figure 4).
This trend was observed in the LDH assay, suggesting
that there was interference on the NADH absorbance
(340 nm) by the CD.
Although the LDH assay is widely used to detect
cytotoxicity of various nanoparticles including CD,
there is limited information on the possible interfer-
ence of LDH on carbon nanodots (CD). Recently, Hsu
et.al reported that the observed cytotoxicity of carbon
nanodots did not increase the release of LDH follow-
ing 24 h incubation of MCF-7, MDA-MD-231 and
HeLa cells with CD concentrations ranging from 0.075
to 0.60 mg/mL (Hsu et al. 2013). However, the authors0
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Figure 4 Absorbance of CD at 340 nm. The reported values (mean ± SD
buffer. Data are expressed as mean ± SEM from three experiments. *, p < 0.failed to further examine whether CD was interfering
with the LDH assay which might alter their conclu-
sion. In this study, we are the first to report that CD
was found to interfere with the NADH absorbance
measurements in the LDH assay in a dose-dependent
manner. Our results suggest that LDH assay should
not be used to evaluate the cytotoxicity of CD that po-
tentially leads to a false conclusion on the cytotoxicity
of carbon nanodots as reported by Hsu et.al (Hsu et al.
2013). The traditional trypan blue staining method
proved to be a viable approach for evaluating the cyto-
toxicity of nanomaterials, whose chemical and phys-
ical properties may not be known. This method has
been used to access the cytotoxicity of multi-walled
carbon nanotubes, however it is fairly time consuming.
Therefore, an improved method is needed to determine
the risk assessment of CD for any future development
or application.0.300 0.450 0.600
tration (mg/mL)
*
*
*
) were corrected by subtracting the background absorbance from PBS
05 vs. control.
Wright et al. SpringerPlus 2014, 3:615 Page 5 of 5
http://www.springerplus.com/content/3/1/615Abbreviations
CA: Citric acid; CD: Carbon nanodots; DMEM: Dulbecco’s Modified Eagle’s
medium, EDA, 1,2-ethylenediamine; LDH: The lactate dehydrogenase;
PBS: Phosphate buffered saline; PC: Positive control.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
ZJ, NHLC and MMFC made contributions to the conception and design.
PCW and HQ performed the experiments. All authors read and approved the
final manuscript.
Funding support
This work was supported in part by National Institutes of Health
(7R15AT005372-02) and a grant from UNCG.
Author details
1Department of Chemistry and Biochemistry, University of North Carolina at
Greensboro, Greensboro, NC 27412, USA. 2Department of Chemistry, Hong
Kong Baptist University, Kowloon Tong, Hong Kong, SAR, China. 3Department
of Nanoscience, Joint School of Nanoscience and Nanoengineering,
Greensboro, NC 27401, USA. 4Department of Biology, University of North
Carolina at Greensboro, Greensboro, NC 27412, USA.
Received: 21 August 2014 Accepted: 10 October 2014
Published: 18 October 2014
References
Baker SN, Baker GA (2010) Luminescent carbon nanodots: emergent nanolights.
Angew Chem Int Ed Engl 49(38):6726–6744, doi: 10.1002/anie.200906623
Beck JD, Offenbacher S (2001) The association between periodontal diseases
and cardiovascular diseases: a state-of-the-science review. Ann
Periodontol 6(1):9–15
Hsu PC, Chang HT (2012) Synthesis of high-quality carbon nanodots from
hydrophilic compounds: role of functional groups. Chem Commun (Camb)
48(33):3984–3986, doi: 10.1039/c2cc30188a
Hsu P-C, Chen P-C, Ou C-M, Chang H-Y, Chang H-T (2013) Extremely high
inhibition activity of photoluminescent carbon nanodots toward cancer cells.
J Mater Chem B 1(13):1774–1781
Hu Q, Paau MC, Zhang Y, Chan W, Gong X, Zhang L, Choi MM (2013) Capillary
electrophoretic study of amine/carboxylic acid-functionalized carbon
nanodots. J Chromatogr A 1304:234–240, doi: 10.1016/j.chroma.2013.07.035
Juzenas P, Kleinauskas A, Luo PG, Sun Y-P (2013) Photoactivatable carbon
nanodots for cancer therapy. Appl Phys Lett 103(6):063701
Kroll A, Pillukat MH, Hahn D, Schnekenburger J (2012) Interference of engineered
nanoparticles with in vitro toxicity assays. Arch Toxicol 86(7):1123–1136
Mossman BT, Borm PJ, Castranova V, Costa DL, Donaldson K, Kleeberger SR
(2007) Mechanisms of action of inhaled fibers, particles and nanoparticles in
lung and cardiovascular diseases. Part Fibre Toxicol 4(4):8974–8977
Prach M, Stone V, Proudfoot L (2013) Zinc oxide nanoparticles and monocytes:
impact of size, charge and solubility on activation status. Toxicol Appl
Pharmacol 266(1):19–26
Shi W, Wang Q, Long Y, Cheng Z, Chen S, Zheng H, Huang Y (2011) Carbon
nanodots as peroxidase mimetics and their applications to glucose
detection. Chem Commun (Camb) 47(23):6695–6697, doi: 10.1039/
c1cc11943e
Tang J, Kong B, Wu H, Xu M, Wang Y, Wang Y, Zhao D, Zheng G (2013) Carbon
nanodots featuring efficient FRET for real‐time monitoring of drug delivery
and two‐photon imaging. Adv Mater 25(45):6569–6574
Tsuji JS, Maynard AD, Howard PC, James JT, C-w L, Warheit DB, Santamaria AB
(2006) Research strategies for safety evaluation of nanomaterials, part IV: risk
assessment of nanoparticles. Toxicol Sci 89(1):42–50Zhang X, He X, Li Y, Zhang Z, Ma Y, Li F, Liu J (2013) A cytotoxicity study of
fluorescent carbon nanodots using human bronchial epithelial cells.
J Nanosci Nanotechnol 13(8):5254–5259
Zhou L, Lin Y, Huang Z, Ren J, Qu X (2012) Carbon nanodots as fluorescence
probes for rapid, sensitive, and label-free detection of Hg2+ and biothiols in
complex matrices. Chem Commun (Camb) 48(8):1147–1149, doi: 10.1039/
c2cc16791c
doi:10.1186/2193-1801-3-615
Cite this article as: Wright et al.: Carbon nanodots interference with
lactate dehydrogenase assay in human monocyte THP-1 cells.
SpringerPlus 2014 3:615.Submit your manuscript to a 
journal and benefi t from:
7 Convenient online submission
7 Rigorous peer review
7 Immediate publication on acceptance
7 Open access: articles freely available online
7 High visibility within the fi eld
7 Retaining the copyright to your article
    Submit your next manuscript at 7 springeropen.com
